YCYe Cheng

Ye Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ye Cheng has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Xin Su

    Department of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, Fujian, China

    10 shared publications
  • Bin Wang

    Department of Cardiology, the Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, Fujian, China

    7 shared publications
  • Huiyuan Kang

    Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases, China

    6 shared publications
  • Min Lai

    Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases, China

    5 shared publications
  • Xiaofang Chen

    Department of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, Fujian, China

    4 shared publications
  • Guoming Zhang

    Department of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, China

    3 shared publications

Latest Publications

  • Open Access

    Dual Percutaneous Management of Dunning Type III Iatrogenic Aortic Dissection During PCI: A Case Report

    by Lin Chen, Fandy Santoso Budiardjo, Xiaofang Chen, Huiyuan Kang, Ye Cheng

    Background: Iatrogenic aortocoronary dissection (IACD) is an uncommon but potentially life-threatening complication of percutaneous coronary intervention (PCI). Case summary: We report the case of a 64-year-old male who developed IACD (Dunning type II) during PCI of right coronary artery. Initial bailout with drug-eluting (DSE) stents implantation but failed to completely exclude a retrograde tear into the aortic root. A larger covered stent (CS) was successfully deployed at the ostium halting the progression of the aortic dissection. Conclusion: This case highlights that for PCI-induced IACD refractory to conventional DES, a CS provides a definitive barrier to halt dissection. A prompt percutaneous bailout, reinforced by strict hemodynamic control and surgical standby, is crucial for managing this catastrophic complication.

  • Open Access

    “One-Stop” Simultaneous TEVAR and Renal Denervation for Stanford Type B Aortic Dissection Complicated by Refractory Hypertension

    by Lin Chen, Hongbin Lin, Xiaofang Chen, Mingchen Sun, Zhaokai Li, Xin Su, Hua Peng, Yan Wang, Ye Cheng


  • Open Access

    Bilateral distal transradial access for subclavian artery stenosis intervention

    by Lin Chen, Xiaofang Chen, Mingchen Sun, Toe Wai Wai Naing, Zhaokai Li, Min Lai, Zixin Tian, Ye Cheng, Huiyuan Kang, Yan Wang

    Background: Conventionally, subclavian stenting has been performed via the femoral artery, but this approach is associated with complications such as bleeding, patient discomfort, and prolonged recovery. The transradial artery access (TRA) has gained popularity due to its lower vascular complication rates, though it carries a risk of radial artery occlusion (RAO). The distal transradial access (dTRA) has emerged as an alternative with lower occlusion rates.Objective: This study aimed to assess the safety and technical feasibility of bilateral distal transradial access for percutaneous interventions in subclavian artery stenosis.Methods: We present 10 cases of subclavian artery stenosis, in whom diagnostic angiography was performed by SIM2 catheter via the contralateral side access. Ipsilateral side distal radial artery was subsequently accessed for balloon-expandable stents delivery.Results: Among the 10 patients, 9 were male and 1 was female, with a mean age of 65.8 years. The systolic pressure difference between the left and right arms was 21.00 mmHg. Among them, 2 cases had 80% stenosis, 2 cases had total occlusive lesions, and 6 cases had 90% stenosis. 1 case had right subclavian artery stenosis, while 9 cases had left subclavian artery stenosis. The results showed a 100% success rate for bilateral distal radial artery puncture and a 100% completion rate for subclavian stenosis intervention procedures. No RAO or subclavian artery restenosis was observed during the 1-month follow-up.Conclusion: In patients with subclavian stenosis bilateral dTRA is a safe and minimally invasive method for patients and ergonomically comfortable for operators.

  • Open Access

    Aortic perforation following percutaneous coronary intervention in a patient with permanent pacemaker: a case report

    by Toe Wai Wai Naing, Xiaofang Chen, Yan Wang, Ye Cheng

    Background: Lead perforation is an uncommon complication of permanent pacemaker (PPM) implantation, occurring in 0.1–0.8% of cases (1). Aortic perforation caused by a pacing lead is rare and has been described only in case reports. Case summary: A 70-year-old Chinese man with a medical history of diabetes mellitus and hypertension presented to the hospital with intermittent chest pain of 3 weeks duration. He was diagnosed with chronic coronary syndrome and underwent percutaneous coronary intervention (PCI) to left anterior descending artery. Two days after post-PCI, he developed shock due to cardiac tamponade. A repeat angiogram was unremarkable; however, during thoracotomy, the right atrial pacing lead of a dual-chamber pacemaker, implanted 6 weeks previously for complete heart block, was found to have perforated the aorta. The patient was discharged in stable condition 20 days after successful repair of the aortic perforation. Discussion: Careful analysis of non-specific chest pain is crucial. This case highlights the importance of considering rare sequelae after multiple cardiac procedures, such as PPM and PCI. This case demonstrates the risk of aortic injury from extra-support guides during PCI, particularly near right atrial pacing leads.


  • Open Access

    Angiopoietin-Like Protein Family-Mediated Functions in Modulating Triglyceride Metabolism and Related Metabolic Diseases

    by Sen Yang, Xin Su, Min Lai, Xiaoxi Liu, Ye Cheng

    Hypertriglyceridemia, characterized by increased triglyceride (TG) concentrations, is considered the most important risk factor for cardiometabolic disorders, including dyslipidemia, atherosclerotic cardiovascular diseases, and non-alcoholic fatty liver disease (NAFLD). Recently, the angiopoietin-like protein (ANGPTL) family, which comprises ANGPTL1 to ANGPTL8, was confirmed to play an important role in modulating lipoprotein lipase (LPL) activity. However, understanding of the underlying mechanisms remains limited. Importantly, emerging evidence has linked several transcriptional and post-transcriptional factors to the potential alteration of TG metabolism via ANGPTL proteins. This review focused on the similarities and differences in the expression, structural features, and modulatory profile of three ANGPTLs: ANGPTL3, ANGPTL4, and ANGPTL8. In addition, the regulatory functions of those three ANGPTLs in modulating LPL were summarized to provide potential therapeutic and clinical strategies for hypertriglyceridemia and its related cardiometabolic disorders.


  • Open Access

    Diverse Cytokines Secreted by Adipocyte in Linking Cardio-Metabolic Disorder and SLE

    by Min Lai, Kai Lin, Xiaofang Chen, Ye Cheng

    Systemic lupus erythematosus (SLE) is a multi-factorial autoimmune-mediated disease with hyper-stimulation of immune cells especially the T lymphocytes. By this method, it might facilitate the systematic damages in multiple tissues and organs. Otherwise, SLE is also correlated with diverse cardio-metabolic comorbidities, including dyslipidemia, insulin resistance, and hypertension. It is worth-noting that the risk of cardio-metabolic disorders is significantly higher compared with the healthy patients which was reported as approximately one-third of SLE patients were proved as obesity. Notably, current focus is shifting to implementing cardio-metabolic protective strategies as well as elucidating underlying mechanisms of lupus-mediated obese status. On the other hand, adipocyte, as the most abundant endocrine cell in fat tissue, are dysfunctional in obese individuals with aberrant secretion of adipokines. It is proposing that the adipokine might link the pathology of cardio-metabolic disorders and SLE, whereas the related mechanism is complicated. In the current review, the functions of adipokine and the potential mechanisms by which the adipokine link cardio-metabolic disorders and SLE was well listed. Furthermore, the recommendations, which identify the adipokine as the potential therapeutic targets for the treatment of cardio-metabolic disorders and SLE, were also summarized.


  • Open Access

    Relationship between the Cell Death-Inducing DNA Fragmentation Factor 45-Like Effector Protein Family and the Risk of Dyslipidemia

    by Jingjin Song, Huiyuan Kang, Ye Cheng

    According to the research, obesity is associated with hyperlipidemia, hypertension, and type 2 diabetes mellitus, which are grouped as metabolic syndrome. Notably, under the obese status, the adipocyte could accumulate excessive lipid as lipid droplets (LDs), leading the dysfunctional fat mass. Recently, emerging evidence has shown that the cell death-inducing DNA fragmentation factor 45-like effector protein (CIDE) family played an important role in regulating lipid metabolism. In addition, diverse CIDE proteins were also confirmed to influence the intracellular lipid metabolism, such as within adipocyte, hepatocyte, and macrophage. Nevertheless, the results which showed the regulatory influence of CIDE proteins are significantly contradictory from in vitro experiments and in vivo clinical studies. Similarly, recent studies have changed the perception of these proteins, redefining them as regulators of lipid droplet dynamics and fat metabolism, which contribute to a healthy metabolic phenotype in humans. However, the underlying mechanisms by which the diverse CIDE proteins alter lipid metabolism are not elucidated. In the current review, the understandings of CIDE proteins in lipid catabolism were well-summarized. On the other hand, the relatively mechanisms were also proposed for the further understandings of the CIDE protein family.


  • Novel Insights of ANGPTL-3 on Modulating Cholesterol Efflux Capacity Induced by HDL Particle

    by Min Lai, Xiang Jiang, Bin Wang, Ye Cheng, Xin Su

    Background: Angiopoietin-like protein 3 (ANGPTL-3) modulates lipid metabolism and the risk of coronary artery disease (CAD), especially stable angina (SA), via suppressing lipoprotein lipase (LPL). However, whether there are other mechanisms is not elucidated yet. The current research explored the modulatory roles of ANGPTL-3 on high-density lipoprotein (HDL), which further affects atherosclerotic development. Methods: A total of 200 individuals were enrolled in the present study. Serum ANGPTL-3 levels were detected via enzyme-linked immunosorbent assays (ELISA). Cholesterol efflux capacity induced by HDL particles was detected through H3-cholesterol loading THP-1 cell. Results: The serum ANGPTL-3 levels presented no significant discordance between the SA group and the non-SA group, whereas the serum ANGPTL-3 levels in type 2 diabetes mellitus (T2DM) group were significantly elevated compared with those in the non-T2DM group [428.3 (306.2 to 736.8) ng/ml vs. 298.2 (156.8 to 555.6) ng/ml, P <0.05]. Additionally, the serum ANGPTL-3 levels were elevated in patients with low TG levels compared to those in patients with high TG levels [519.9 (377.6 to 809.0) ng/ml vs. 438.7 (329.2 to 681.0) ng/ml, P <0.05]. By comparison, the individuals in the SA group and T2DM group presented decreased cholesterol efflux induced by HDL particles [SA: (12.21±2.11)% vs. (15.51±2.76)%, P <0.05; T2DM: (11.24±2.13)% vs. (14.65±3.27)%, P <0.05]. In addition, the serum concentrations of ANGPTL-3 were inversely associated with the cholesterol efflux capacity of HDL particles (r=-0.184, P <0.05). Through regression analysis, the serum concentrations of ANGPTL-3 were found to be an independent modulator of the cholesterol efflux capacity of HDL particles (standardized β=-0.172, P <0.05). Conclusion: ANGPTL-3 exhibited a negative modulatory function on cholesterol efflux capacity induced by HDL particles.


  • Relationship between inflammatory-related cytokines with aortic dissection

    by Jingjin Song, Hua Peng, Min Lai, Huiyuan Kang, Xiaofang Chen, Ye Cheng, Xin Su